alpha-Synuclein: Luminex Assays
alpha -Synuclein is a member of a family of small, soluble proteins that also include beta -, and gamma -Synuclein. alpha -Synuclein is one of the most highly expressed proteins in the human brain. It is predominantly expressed in neurons while lower levels are found in glial cells. alpha -Synuclein protein accumulates in the presynaptic region of nerve terminals where it is thought to play a role in synaptic vesicle biology, but its exact function remains largely unknown. The protein structure cycles between a free, partially unfolded form and a helical, membrane-bound form.
In alpha-Synucleinopathies, protein aggregates containing alpha-Synuclein protein form called Lewy Bodies, glial inclusions, or axonal spheroids depending on the disease. Lewy Bodies are associated with the pathogenesis of Parkinson's disease dimentia. Post-secondary modifications and solubility of alpha -Synuclein are thought to affect Lewy body formation. Phosphorylation level increases before Lewy body formation and increased lipid association of alpha-Synuclein promotes formation as well. alpha -Synuclein protein aggregates have also been found associated with amyloid plaques in Alzheimer's disease. In vitro, alpha -Synuclein oligomers cause neuronal inflammation, degeneration, and cell death. Recombinant alpha -Synuclein protein can be used to study aggregation and toxicity in a controlled environment.
Products:
1 result for "alpha-Synuclein Luminex Assays" in Products
1 result for "alpha-Synuclein Luminex Assays" in Products
alpha-Synuclein: Luminex Assays
alpha -Synuclein is a member of a family of small, soluble proteins that also include beta -, and gamma -Synuclein. alpha -Synuclein is one of the most highly expressed proteins in the human brain. It is predominantly expressed in neurons while lower levels are found in glial cells. alpha -Synuclein protein accumulates in the presynaptic region of nerve terminals where it is thought to play a role in synaptic vesicle biology, but its exact function remains largely unknown. The protein structure cycles between a free, partially unfolded form and a helical, membrane-bound form.
In alpha-Synucleinopathies, protein aggregates containing alpha-Synuclein protein form called Lewy Bodies, glial inclusions, or axonal spheroids depending on the disease. Lewy Bodies are associated with the pathogenesis of Parkinson's disease dimentia. Post-secondary modifications and solubility of alpha -Synuclein are thought to affect Lewy body formation. Phosphorylation level increases before Lewy body formation and increased lipid association of alpha-Synuclein promotes formation as well. alpha -Synuclein protein aggregates have also been found associated with amyloid plaques in Alzheimer's disease. In vitro, alpha -Synuclein oligomers cause neuronal inflammation, degeneration, and cell death. Recombinant alpha -Synuclein protein can be used to study aggregation and toxicity in a controlled environment.
Products:
Luminex Discovery Assays provide the most flexible assays on the market. These panels are completely customizable using our large menu of human, mouse, and rat analytes, making them the perfect tool for biomarker discovery and screening.
Build your own Luminex Assay with our Luminex Assay Customization Tool.